Prescription opioid use disorders and deaths increased for the most recent 10 years tracked, even though the percentage of non-medical use of prescription opioids decreased, according to a new study.
Prescription opioid use disorders and deaths increased for the most recent 10 years tracked, even though the percentage of non-medical use of prescription opioids decreased, according to a new study.
Related: FDA nixes one painkiller, recommends another
The study, published in the Oct 13, 2015, issue of JAMA, was led by Beth Han, MD, PhD, with the Substance Abuse and Mental Health Services Administration (SAMHSA) in Rockville, Md. Han and colleagues reviewed data on more than 472,00 people, aged 18 to 64 years, who participated in the 2003-2013 National Surveys on Drug Use and Health.
Related: PCORI awards prison system $2M to study naltrexone benefit in opioid abuse
Here are the top new findings on opioid use and abuse:
FDA Approves Subcutaneous Tecentriq to Treat Multiple Cancers
September 13th 2024Tecentriq Hybreza can be administered over seven minutes, compared with 30 to 60 minutes for IV infusion of Tecentriq. There is no word yet on when Tecentriq Hybreza will be available or what the price will be.
Read More
FDA Warns of Liver Injury with Veozah for Hot Flashes
September 12th 2024The FDA has identified a probable case of serious drug induced liver injury that occurred in a woman in the United States who had received Veozah. The agency is requiring additional liver blood testing after starting therapy.
Read More